1. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation. (May 2022) Authors: Boekhoff, M.R.; Bouwmans, R.; Doornaert, P.A.H.; Intven, M.P.W.; Lagendijk, J.J.W.; van Lier, A.L.H.M.W.; Rasing, M.J.A.; van de Ven, S.; Meijer, G.J.; Mook, S. Journal: Clinical and translational radiation oncology Issue: Volume 34(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience. (January 2021) Authors: Intven, M.P.W.; de Mol van Otterloo, S.R.; Mook, S.; Doornaert, P.A.H.; de Groot-van Breugel, E.N.; Sikkes, G.G.; Willemsen-Bosman, M.E.; van Zijp, H.M.; Tijssen, R.H.N. Journal: Radiotherapy and oncology Issue: Volume 154(2021) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0725 Multimodality imaging employing FDG-PET/CT paves the way for de-escalation of the elective dose. (April 2019) Authors: Van den Bosch, S.; Doornaert, P.A.H.; Terhaard, C.H.J.; Kaanders, J.H.A.M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗